Adenocarcinoma of the Pancreas Terminated Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01318642Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the PancreasTreatment
NCT02124369Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)Treatment
NCT01921751High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryTreatment